Valeant Is Said to Hire Zoetis’ Paul Herendeen as CFO
This article is for subscribers only.
Valeant Pharmaceuticals International Inc. is preparing to name Paul Herendeen, an executive at veterinary drugmaker Zoetis Inc., as its new chief financial officer, according to people familiar with the matter.
The announcement will mark the latest management change at the embattled drugmaker, which replaced Chief Executive Officer Michael Pearson earlier this year. Herendeen has been working as CFO at Zoetis since September 2014. Before that, he was CFO of specialty drugmaker Warner Chilcott Plc, according to Zoetis’s website.